Jamie E. Anderson

Ms. Jamie E. Anderson

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ARAlexander E. Ropper
Alexander E. Ropper
DTDevang K. Thakor
Devang K. Thakor
IHInBo Han
InBo Han
DYDou Yu
Dou Yu
Xiang ZengXiang Zeng
Xiang Zeng
Yang D. TengYang D. Teng
Yang D. Teng
Significance: We developed a platform technology to determine therapeutic mechanisms of human mesenchymal stromal stem cells (hMSCs) in a dorsal root ganglion coculture system and an intraspinal cord implantation model. The unique poly(lactic- co- glycolic) acid scaffolding augments hMSC stemness, engraftment, and function without neural transdifferentiation or mesenchymal lineage development, resulting in robust motosensory improvement, pain and tissue damage mitigation, and myelin preservation in adult rat spinal cord after injury. The scaffolded hMSC-derived neurotrophism, neurogenesis, angiogenesis, antiautoimmunity, and antiinflammation support the propriospinal network, neuromuscular junctions, and serotonergic reticulospinal reinnervation to activate the central pattern generator for restoring hindlimb locomotion. Our findings illuminate “recovery neurobiology”—i.e., the injured spinal cord may deploy polysynaptic neural circuits different from normal adulthood pathways for postinjury improvement.

28 March 2016 in Glia
Verified
Journal Article
Closed access
PDF file
NVNina Vardjan
Nina Vardjan
AHAnemari Horvat
Anemari Horvat
JAJamie E. Anderson
Jamie E. Anderson
DYDou Yu
Dou Yu
DCDeborah Croom
Deborah Croom
Robert ZorecRobert Zorec
Robert Zorec

1 December 2021 in Pediatrics
Verified
Journal Article
Open access
PDF file
ACAaron S. Coyner
Aaron S. Coyner
JCJimmy S. Chen
Jimmy S. Chen
PSPraveer Singh
Praveer Singh
RSRobert L. Schelonka
Robert L. Schelonka
BJBrian K. Jordan
Brian K. Jordan
JCJ. Peter Campbell
J. Peter Campbell
Video Abstract Video Abstract Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Screening and treatment reduces this risk, but requires multiple examinations of infants, most of whom will not develop severe disease. Previous work has suggested that artificial intelligence may be able to detect incident severe disease (treatment-requiring retinopathy of prematurity [TR-ROP]) before clinical diagnosis. We aimed to build a risk model that combined artificial intelligence with clinical demographics to reduce the number of examinations without missing cases of TR-ROP. Infants undergoing routine ROP screening examinations (1579 total eyes, 190 with TR-ROP) were recruited from 8 North American study centers. A vascular severity score (VSS) was derived from retinal fundus images obtained at 32 to 33 weeks’ postmenstrual age. Seven ElasticNet logistic regression models were trained on all combinations of birth weight, gestational age, and VSS. The area under the precision-recall curve was used to identify the highest-performing model. The gestational age + VSS model had the highest performance (mean ± SD area under the precision-recall curve: 0.35 ± 0.11). On 2 different test data sets (n = 444 and n = 132), sensitivity was 100% (positive predictive value: 28.1% and 22.6%) and specificity was 48.9% and 80.8% (negative predictive value: 100.0%). Using a single examination, this model identified all infants who developed TR-ROP, on average, >1 month before diagnosis with moderate to high specificity. This approach could lead to earlier identification of incident severe ROP, reducing late diagnosis and treatment while simultaneously reducing the number of ROP examinations and unnecessary physiologic stress for low-risk infants.

1 April 2015 in Cell Transplantation
Verified
Journal Article
Open access
HHHariprakash Haragopal
Hariprakash Haragopal
DYDou Yu
Dou Yu
Xiang ZengXiang Zeng
Xiang Zeng
SKSoo-Woo Kim
Soo-Woo Kim
IHIn-Bo Han
In-Bo Han
Yang D. TengYang D. Teng
Yang D. Teng
Rapid loss of stemness capacity in purified prototype neural stem cells (NSCs) remains a serious challenge to basic and clinical studies aiming to repair the central nervous system. Based on the essential role of mesodermal guidance in the process of neurulation, we hypothesized that coculture of human NSCs (hNSCs) with human bone marrow-derived mesenchymal stromal stem cells (hMSCs) could enhance the stemness of hNSCs through Notch-1 signaling. We have now tested the hypothesis by assessing behaviors of hNSCs and hMSCs under systematically designed coculture conditions relative to monocultures, with or without Notch-1 manipulation in vitro. Our data demonstrate that expression levels of Notch-1 and Hes-1 as determined by immunocytochemistry are significantly higher in hNSCs cocultured with hMSCs than those of controls. Furthermore, coculturing significantly increases immunoreactivity of CD15, a neural stemness marker, but decreases CD24, a marker of neural/neuronal commitment in hNSCs. The effect is independent from the physical status of cell growth since coculture and notch signaling actually promotes hNSC adhesion. Importantly, coculture with hMSCs markedly augments hNSC proliferation rate (e.g., higher yield in G2/M phase subpopulation in a notch-dependent manner detected by flow cytometry) without diminishing their lineage differentiation capabilities. The results suggest that coculture of hNSCs with hMSCs enhances stemness biology of hNSCs partially via activation of Notch-1 signal transduction. Our finding sheds new light on mesoderm-ectoderm cell fate determination via contact-based hMSC-hNSC interactions and provides mechanistic leads for devising effective regimens to sustain and augment stemness of in vitro established hNSC and hMSC lines for basic science, translational and clinical applications.

7 August 2012 in Langmuir
Verified
Journal Article
Closed access
SNSunaro C. Ngourn
Sunaro C. Ngourn
HBHillary A. Butts
Hillary A. Butts
APAlexander R. Petty
Alexander R. Petty
JAJamie E. Anderson
Jamie E. Anderson
AGAren E. Gerdon
Aren E. Gerdon

1 September 2015 in Experimental Neurology
Verified
Journal Article
Closed access
ARAlexander E. Ropper
Alexander E. Ropper
Xiang ZengXiang Zeng
Xiang Zeng
JAJamie E. Anderson
Jamie E. Anderson
DYDou Yu
Dou Yu
IHInBo Han
InBo Han
Yang D. TengYang D. Teng
Yang D. Teng